These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29094647)

  • 1. Regenerative medicine and responsible research and innovation: proposals for a responsible acceleration to the clinic.
    Webster A
    Regen Med; 2017 Oct; 12(7):853-864. PubMed ID: 29094647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA and NIST collaboration on standards development activities supporting innovation and translation of regenerative medicine products.
    Arcidiacono JA; Bauer SR; Kaplan DS; Allocca CM; Sarkar S; Lin-Gibson S
    Cytotherapy; 2018 Jun; 20(6):779-784. PubMed ID: 29784433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying viable regulatory and innovation pathways for regenerative medicine: a case study of cultured red blood cells.
    Mittra J; Tait J; Mastroeni M; Turner ML; Mountford JC; Bruce K
    N Biotechnol; 2015 Jan; 32(1):180-90. PubMed ID: 25094050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teaching Responsible Research and Innovation: A Phronetic Perspective.
    Mejlgaard N; Christensen MV; Strand R; Buljan I; Carrió M; Cayetano I Giralt M; Griessler E; Lang A; Marušić A; Revuelta G; Rodríguez G; Saladié N; Wuketich M
    Sci Eng Ethics; 2019 Apr; 25(2):597-615. PubMed ID: 29417391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Devices of Responsibility: Over a Decade of Responsible Research and Innovation Initiatives for Nanotechnologies.
    Shelley-Egan C; Bowman DM; Robinson DKR
    Sci Eng Ethics; 2018 Dec; 24(6):1719-1746. PubMed ID: 29019058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distributive justice and regenerative medicine.
    Gardner J
    Regen Med; 2017 Oct; 12(7):865-874. PubMed ID: 29095111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introducing responsible innovation in health: a policy-oriented framework.
    Pacifico Silva H; Lehoux P; Miller FA; Denis JL
    Health Res Policy Syst; 2018 Sep; 16(1):90. PubMed ID: 30200985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consolidating RRI and Open Science: understanding the potential for transformative change.
    Shelley-Egan C; Gjefsen MD; Nydal R
    Life Sci Soc Policy; 2020 Sep; 16(1):7. PubMed ID: 32869131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-engineering the innovator-clinic interface for adoption of advanced therapies.
    Medcalf N
    Regen Med; 2021 Mar; 16(3):295-308. PubMed ID: 33764156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflections on different governance styles in regulating science: a contribution to 'Responsible Research and Innovation'.
    Landeweerd L; Townend D; Mesman J; Van Hoyweghen I
    Life Sci Soc Policy; 2015; 11():8. PubMed ID: 26260065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardising Responsibility? The Significance of Interstitial Spaces.
    Wickson F; Forsberg EM
    Sci Eng Ethics; 2015 Oct; 21(5):1159-80. PubMed ID: 25344842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Societal impact of synthetic biology: responsible research and innovation (RRI).
    Gregorowius D; Deplazes-Zemp A
    Essays Biochem; 2016 Nov; 60(4):371-379. PubMed ID: 27903824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The social management of biomedical novelty: Facilitating translation in regenerative medicine.
    Gardner J; Webster A
    Soc Sci Med; 2016 May; 156():90-7. PubMed ID: 27019143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Science communication in regenerative medicine: Implications for the role of academic society and science policy.
    Shineha R; Inoue Y; Ikka T; Kishimoto A; Yashiro Y
    Regen Ther; 2017 Dec; 7():89-97. PubMed ID: 30271857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem Cell and Regenerative Medicine Global Conference (SCRGC) 2016 (August 23-24, 2016 - Gyeonggi-do, Korea).
    Vertès A
    Drugs Today (Barc); 2016 Oct; 52(10):577-583. PubMed ID: 27910966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticipating the clinical adoption of regenerative medicine: building institutional readiness in the UK.
    Gardner J; Webster A; Barry J
    Regen Med; 2018 Jan; 13(1):29-39. PubMed ID: 29360014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The politics of buzzwords at the interface of technoscience, market and society: the case of 'public engagement in science'.
    Bensaude Vincent B
    Public Underst Sci; 2014 Apr; 23(3):238-53. PubMed ID: 24495899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contextualizing Security Innovation: Responsible Research and Innovation at the Smart Border?
    Klimburg-Witjes N; Huettenrauch FC
    Sci Eng Ethics; 2021 Feb; 27(1):13. PubMed ID: 33599880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerating Innovation: Complexity, Regulation, and Temporality.
    Webster A
    Front Sociol; 2019; 4():13. PubMed ID: 33869340
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.